Inventor
BERTOZZI FABIO
IT11 patents
⚠️ This page may combine multiple inventors who share the name “BERTOZZI FABIO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
FONDAZIONE ST ITALIANO TECNOLOGIA
8 patentsUS12492193B2Dec 9, 2025
Pyrazole derivatives for the treatment of cystic fibrosis
FONDAZIONE ST ITALIANO TECNOLOGIA0 citations57
US11597723B2Mar 7, 2023
Pyrazole derivatives for the treatment of cystic fibrosis
FONDAZIONE ST ITALIANO TECNOLOGIA0 citations57
US10745407B2Aug 18, 2020
Heterocyclic derivatives for the treatment of cystic fibrosis
FONDAZIONE ST ITALIANO TECNOLOGIA1 citations56
US10364242B2Jul 30, 2019
Modulation of N-acylethanolamine-hydrolysing acid amidase (NAAA) for disease treatment
FONDAZIONE ST ITALIANO TECNOLOGIA0 citations50
US10968225B2Apr 6, 2021
Compounds and compositions for the treatment of cystic fibrosis
FONDAZIONE ST ITALIANO TECNOLOGIA0 citations45
US11999734B2Jun 4, 2024
Compounds and compositions for the treatment of cystic fibrosis
FONDAZIONE ST ITALIANO TECNOLOGIA0 citations44
US12391680B2Aug 19, 2025
Compounds and compositions for the treatment of cystic fibrosis
FONDAZIONE ST ITALIANO TECNOLOGIA0 citations43
US10865194B2Dec 15, 2020
Therapeutically active bicyclic-sulphonamides and pharmaceutical compositions
FONDAZIONE ST ITALIANO TECNOLOGIA0 citations30
UNIV CALIFORNIA
3 patentsUS9353075B2May 31, 2016
Disubstituted beta-lactones as inhibitors of N-acylethanolamine acid amidase (NAAA)
UNIV CALIFORNIA3 citations70
US9908848B2Mar 6, 2018
Amide derivatives of lactam based N-acylethanolamine acid amidase (NAAA) inhibitors
UNIV CALIFORNIA1 citations48
US9828338B2Nov 28, 2017
Carbamate derivatives of lactam based N-acylethanolamine acid amidase (NAAA) inhibitors
UNIV CALIFORNIA1 citations46